ClinicalTrials.gg
CompletedNCT05430997Updated Jul 17, 2025

Hypothermia Risk Prediction Combined With Active Insulation Management in Geriatric Surgery

An interventional study of IOB Warming Unit (WU505) + Inflatable Warming Blanket and cover with a quilt from the neck to both feet in Hypothermia; Anesthesia and Body Temperature Changes, sponsored by First Affiliated Hospital of Chongqing Medical University. Completed at 1 site in China. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-07-17.

Sponsored by First Affiliated Hospital of Chongqing Medical University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,360
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

To evaluate the effectiveness and safety of hypothermia risk prediction combined with active warming management to reduce intraoperative hypothermia in elderly patients undergoing elective general anesthesia, improve the quality of anesthesia management, and enhance patients' awareness of the work of anesthesiologists.

02

Conditions studied

  • Hypothermia; Anesthesia
  • Body Temperature Changes
03

In context

Hypothermia

449 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's enrollment of 1,360 is above the median of 77 across 328 interventional studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

First Affiliated Hospital of Chongqing Medical University is the lead sponsor of 95 studies on the registry; 42 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 60 years, male or female.
  2. Elective general anesthesia for surgery.
  3. Operative time ≥ 30 min.
  4. Preoperative body temperature within the normal range.
  5. Normal preoperative bleeding and clotting time.

Exclusion criteria

Exclusion Criteria:

  1. Mental illness.
  2. High or low basal hypothermia with high or low metabolic disease (patients with central hyperthermia include those with cerebrovascular vascular disease, traumatic brain injury and brain surgery, epilepsy, central hyperthermia due to acute hydrocephalus; thermoregulatory abnormalities including malignant hyperthermia (MHS), neuroleptic malignant syndrome and those with definite evidence of diagnosed hypo- or hyperthyroidism and current abnormal thyroid function).
  3. Impaired skin insulation barriers such as large skin burns.
  4. Infectious fever.
  5. Other causes of body temperature above 38.5 °C three days before surgery.
  6. Other persons deemed unsuitable by the investigator to participate in the clinical trial.
  7. Refusal to sign the form.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,360 participants (actual)

Study arms

  • Active comparator
    Group A: conventional management

    The ambient temperature of the operating room was set at 23±2 ℃ and the relative humidity was 50% to 60%. Intraoperative infusion fluids, blood products and rinsing fluid were warmed. Patients were given quilts to cover after entering the operating room, and the quilts covered from the neck to both the feet.

    Device: cover with a quilt from the neck to both feet

  • Experimental
    Group B: Hypothermia Risk Prediction Joint Active Insulation Management

    In the test group, after the assessment of the "Intraoperative Hypothermia Risk Prediction APP", patients who were "prompted/recommended to use active warming measures" were actively warmed by inflatable warming (IOB Warming Unit (WU505) + Inflatable Warming Blanket) after admission to the room. Warming Unit (WU505) + Warming Blanket (IOB Warming Blanket)) was used for active warming. The air inlet was connected to the air catheter, and the host temperature was set at 38 ℃ with "high" air speed. During the operation, the thermal blanket is covered with non-surgical sterilization area (such as both shoulders, torso, healthy limbs, etc.), and the host temperature is adjusted to 38 ℃ for thermal insulation. The temperature and wind speed were adjusted in time to maintain the oropharyngeal temperature at 36.2℃~37.2℃ by monitoring the body temperature at any time during the operation.

    Device: IOB Warming Unit (WU505) + Inflatable Warming Blanket

Interventions

  • DeviceIOB Warming Unit (WU505) + Inflatable Warming Blanket

    The inflatable warming method (Inflatable Warming Unit (IOB Warming Unit, WU505) + Inflatable Warming Blanket (IOB Warming Blanket)) is a common clinical warming technique in anesthesiology, which is well tolerated by patients and safe and effective. The anesthesiology department has established standard operating procedures for the above-mentioned non-invasive operations.

  • Devicecover with a quilt from the neck to both feet

    The patient was covered with a quilt from the neck to both feet after entering the operating room.

06

What researchers measure

Primary outcomes

  1. Incidence of intraoperative hypothermia

    Intraoperative hypothermia, defined as a core temperature below 36 °C

    Time frame: Up to 24 hours, from the time of entry into the operating room to the time of exit from the operating room.

Secondary outcomes

  1. Postprocedural Shivering

    A compensatory response of the body to hypothermic stimuli that cause rapid rhythmic,Once the procedure is completed, the patient will be extubated and the presence or absence of shivering will be recorded up to 60 minutes after the extubation with the Badjatia 2008 scale consisting of a gradual evaluation of 0 to 3 points. With scores greater or equal to 1, shivering is considered established. contraction of skeletal muscle for thermogenesis

    Time frame: up to 60 minutes

  2. Intraoperative bleeding volume

    Routine intraoperative monitoring indicators

    Time frame: up to 24 hours after surgery

  3. Postoperative blood count

    The number of red blood cells, white blood cells and platelets in the blood is calculated by smearing the blood in a routine blood test and looking at it under the microscope.

    Time frame: up to 24 hours after surgery

  4. 30-day postoperative readmission

    Routine postoperative monitoring indicators

    Time frame: 30 days after surgery

  5. 6-month postoperative complications (surgical complications, pulmonary infections, blood clots)

    Routine postoperative monitoring indicators

    Time frame: 6 months after surgery

  6. 30-day postoperative complications (surgical complications, pulmonary infections, blood clots)

    Routine postoperative monitoring indicators

    Time frame: 30 days after surgery

  7. 30-day postoperative mortality

    Routine postoperative monitoring indicators

    Time frame: 30 days after surgery

  8. Postoperative coagulation index

    Routine intraoperative monitoring indicators

    Time frame: up to 24 hours after surgery

  9. Intraoperative blood transfusion volume

    Routine intraoperative monitoring indicators, recorded according to intraoperative blood transfusion volume

    Time frame: 15 minutes before the end of the surgery

  10. Intraoperative fluid transfusion

    Routine intraoperative monitoring indicators, the general rehydration amount for surgical patients is 4-6 ml per kilogram of body weight per hour

    Time frame: 15 minutes before the end of the surgery

  11. intraoperative flushing fluid volume

    Routine intraoperative monitoring indicators, record the amount of intraoperative irrigation fluid used, depending on the procedure

    Time frame: 15 minutes before the end of the surgery

  12. Shivering severity

    The post operative shivering scale of Badjatia 2008 will be used. It consist of a gradual evaluation of 0 to 3 points, with 0 being the absence of shivering, 1 slight shivering, 2 moderate and 3 severe. The highest score obtained will be recorded within the measurements made every 5 minutes in the first 60 minutes after extubation.

    Time frame: 60 minutes

07

Study locations

1 site
  • First Affiliated Hospital of Chongqing Medical University
    Chongqing, 400010, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05430997
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Responsible party
Min Su (Professor.Min, First Affiliated Hospital of Chongqing Medical University) — Principal investigator
First posted
Jun 24, 2022
Start date
Jun 1, 2022
Primary completion
Jul 1, 2023
Completion
Aug 1, 2023
Last update
Jul 17, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion